Status message

As part of our system maintenance and upgrade processes, beginning Friday, December 4th, 8:00 PM ET, the website login and online services will be unavailable. We anticipate the website to return to its functional by 11:30 PM ET Sunday, December 6th

You are here

OARSI Resources: FDA

 

OARSI White Paper- OA as a Serious Disease

By Various

~The Pre-Competitive Consortium for Osteoarthritis, an initiative of the Osteoarthritis Research Society International, submitted a White Paper entitled Osteoarthritis as a Serious Disease to the U.S. Food and Drug Administration on December 1, 2016.
The mission of the Pre-Competitive Consortium for Osteoarthritis (PCCOA) is to advance the development of structure modifying therapies for...

Category: Biomarkers

Tags: White Paper, Serious Disease, FDA